Clinical and Histopathological Aspects of MRONJ in Cancer Patients

Clinical and Histopathological Aspects of MRONJ in Cancer Patients

Medication-related osteonecrosis of the jaw (MRONJ) is a major complication of bisphosphonate treatment in cancer patients, and its etiology is not completely clarified. The study’s goal is to find connections between the clinical and histopathological characteristics of osteonecrosis and bisphospho...

Full description

Bibliographic Details
Main Authors:	George Adrian Ciobanu, Laurențiu Mogoantă, Adrian Camen, Mihaela Ionescu, Daniel Vlad, Ionela Elisabeta Staicu, Cristina Maria Munteanu, Mircea Ionuț Gheorghiță, Răzvan Mercuț, Elena Claudia Sin, Sanda Mihaela Popescu
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Journal of Clinical Medicine
Subjects:	osteonecrosis zoledronic acid histopathology cancer patients bisphosphonate
Online Access:	https://www.mdpi.com/2077-0383/12/10/3383

Similar Items

Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid
by: George Adrian Ciobanu, et al.
Published: (2023-05-01)

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01)

Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid
by: George Adrian Ciobanu, et al.
Published: (2023-09-01)

Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
by: Saeed Moradi, et al.
Published: (2023-03-01)

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study
by: Milad Etemadi Sh, et al.
Published: (2023-07-01)

MRONJ and VIT D insufficiency
by: Gholamreza Shirani, et al.
Published: (2021-07-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

The feasibility of discriminating BRONJ lesion bone with Raman spectroscopy
by: Chengwan Xia, et al.
Published: (2023-05-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Gabor Kammerhofer, et al.
Published: (2023-04-01)

Local Administration of Bisphosphonate-soaked Hydroxyapatite for the Treatment of Osteonecrosis of the Femoral Head in Rabbit
by: Jin-Hui Ma, et al.
Published: (2016-01-01)

Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ
by: Ilaria Roato, et al.
Published: (2023-10-01)

Porphyromonas gingivalis Induces Bisphosphonate-Related Osteonecrosis of the Femur in Mice
by: Shuxuan Wu, et al.
Published: (2022-06-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
by: Raed AlRowis, et al.
Published: (2022-03-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats
by: Leomar Emanuel de Almeida MECCA, et al.
Published: (2022-06-01)

Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
by: Xin Chen, et al.
Published: (2021-11-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Polyarthritis following infusion of zoledronic acid: a case study
by: T. Campbell
Published: (2023-07-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Evaluation of Preventive Role of Systemically Applied Erythropoietin after Tooth Extraction in a Bisphosphonate-Induced MRONJ Model
by: Gonca Duygu, et al.
Published: (2023-05-01)

Zoledronic acid promotes osteoclasts ferroptosis by inhibiting FBXO9-mediated p53 ubiquitination and degradation
by: Xingzhou Qu, et al.
Published: (2021-12-01)

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
by: Gioacchino Catania, et al.
Published: (2016-12-01)

Delayed alveolar bone repair and osteonecrosis associated with Zoledronic Acid therapy in rats: macroscopic, microscopic and molecular analysis
by: Gustavo Zanna FERREIRA, et al.
Published: (2020-09-01)

Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
by: Camille Gaudet, et al.
Published: (2022-12-01)

Osteonecrosis de los maxilares inducida por bifosfonatos: lo que el odontólogo debe saber hoy: pautas y protocolos
by: Jorge Giribone, et al.

Medication-Related Osteonecrosis of the Mandible Treated with Marginal Resection: A Case Report
by: Maciej Chęciński, et al.
Published: (2022-06-01)

Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing
by: Songmi Kim, et al.
Published: (2022-04-01)

DOXYCYCLINE BONE LABELING – IMPACT ON MRONJ TREATMENT
by: Vlad Daniel, et al.
Published: (2022-01-01)

Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw
by: Siri Paulo, et al.
Published: (2020-04-01)

Bisphosphonates: An update to the general dentist
by: Varun Dahiya, et al.
Published: (2013-01-01)

Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study
by: Mohammad Reza Jamalpour, et al.
Published: (2022-06-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

Spontaneous Osteogenic Potential of Periosteum after Segmental Mandibulectomy in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 14 Cases
by: Youngmin Kwon, et al.
Published: (2023-04-01)

Tips and Tricks and Clinical Outcome of Cryopreserved Human Amniotic Membrane Application for the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Pilot Study
by: Stéphane Odet, et al.
Published: (2022-07-01)

How Surgery Affects Patients with Jaw Osteonecrosis? A Quality of Life Analysis Study
by: Ahmet Biçer, et al.
Published: (2022-04-01)

Bisphosphonates: An update
by: Nalliappan Ganapathy, et al.
Published: (2012-01-01)

Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study
by: Ashley A. Smith, et al.
Published: (2023-01-01)

New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy
by: Agostino Guida, et al.
Published: (2021-01-01)